Login / Signup

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.

Daniel P CookAshley Y WuChristopher M ThomasRobert G HamiltonRay Stokes PeeblesVern Eric Kerchberger
Published in: Allergy (2024)
Keyphrases
  • cystic fibrosis
  • pseudomonas aeruginosa
  • lung function
  • oxidative stress
  • cardiovascular events
  • cancer therapy
  • risk factors
  • stem cells
  • drug delivery
  • cell therapy
  • smoking cessation